If your child needs a stronger prescription year after year, you are not alone, and acting on it is exactly the right instinct. The faster a child's nearsightedness progresses, the higher their lifetime risk of serious eye problems like retinal detachment and glaucoma, which is why slowing it matters. Mudgil Eye Associates offers myopia control for Glen Mills families about 18 minutes away via Route 202 or Route 1, with both MiSight contact lenses, which are FDA-approved to slow myopia progression, and low-dose atropine, guided by a Johns Hopkins fellowship-trained pediatric ophthalmologist and a residency-trained pediatric optometrist. We are a complete MD-and-OD team, so if anything beyond myopia ever comes up, expert care is already in place.
Glen Mills sits in Delaware County along Route 1 and the Baltimore Pike corridor, and families from Concord Township, Brinton Lake, Thornbury, and Garnet Valley regularly make the short trip to our West Chester office. Many local parents come in having noticed the same thing: a prescription that was fine last year suddenly needs another bump. That pattern is exactly what myopia control is built to address.
Myopia control is not a single product you buy once; it is a multi-year plan that we measure, adjust, and monitor as your child grows. Between screen-filled classrooms, heavy homework loads, and less outdoor time than earlier generations enjoyed, more Glen Mills children are becoming nearsighted earlier than their parents did. Because we are a complete MD-and-OD practice, a residency-trained pediatric optometrist and a Johns Hopkins fellowship-trained pediatric ophthalmologist work under one roof, so whatever your child's eyes need is already in place.
MiSight is an FDA-approved daily contact lens proven to slow the progression of myopia in children. Your child wears it during the day, and it both corrects vision and helps keep the prescription from climbing as quickly. We are listed on the manufacturer's official provider locator.
Dr. A. Vijay Mudgil completed his pediatric ophthalmology fellowship at the Wilmer Eye Institute, Johns Hopkins, and our optometrist provides residency-trained pediatric care. Your child's myopia plan is overseen by pediatric eye specialists who do this every day.
For children who are not ready for contact lenses, we also offer low-dose atropine eye drops, a simple nightly drop widely used to help slow myopia progression. We help you choose the approach that fits your child best, and some children do well with a combination.
We are a complete MD-and-OD practice. A fellowship-trained pediatric ophthalmologist works alongside our optometrist, so if your child ever needs more than myopia control, a pediatric ophthalmologist's expertise is already part of their care.
Myopia, or nearsightedness, is easy to picture as simply needing glasses to see the board, but the underlying change is physical. In a nearsighted eye, the eyeball has grown a little too long from front to back, an effect eye doctors call axial elongation. With the eye too long, light from distant objects lands just short of the retina rather than on it, so distance looks blurry while close-up stays sharp. Glasses and ordinary contacts refocus that light, but they do nothing to change the eye's length or slow its growth. Changing that trajectory is the entire purpose of myopia control.
The aim is bigger than a slightly thinner lens next year. Every step up in nearsightedness means a longer, more stretched eye and a higher lifetime chance of problems such as retinal detachment, glaucoma, earlier cataract, and myopic maculopathy in adulthood. Slowing how fast the myopia advances during childhood is meant to leave your child with a lower final adult prescription, and a lower prescription carries lower long-term risk. To be clear, myopia control does not cure or reverse the nearsightedness a child already has, and results vary from child to child, but for most children it slows the pace meaningfully.
Childhood myopia is climbing across the country, and the neighborhoods around Glen Mills are no exception. Heredity is a big driver, so a child with one or two nearsighted parents starts with higher odds, but daily life plays its part too. Hours of close focus for reading, homework, and devices, paired with fewer hours outdoors in bright natural light, are linked to faster progression. One of the most reliable, low-cost steps any Concord Township family can take is guarding regular outdoor time, which is why we talk about everyday habits right alongside any lens or drop.
For a Glen Mills child who is ready to wear a contact lens, MiSight 1 day is often the first option we reach for. It is the only soft contact lens the FDA has approved specifically to slow myopia progression in children, and because it is a daily-disposable lens worn through the day, it also corrects your child's distance vision while it is worn. Many families find that convenient at recess or on the field, and results vary from child to child.
A MiSight lens feels like any other soft contact, but it is built with concentric treatment rings. The center of the lens gives clear distance vision, while the surrounding zones bring part of the light to focus slightly ahead of the peripheral retina, a cue that appears to ease the eye's drive to keep lengthening. Across the manufacturer's multi-year clinical study, children in MiSight lenses progressed on average markedly slower than a comparison group, on the order of a 59 percent reduction in the rate of progression over three years. That figure comes from that clinical study, and how much any one child benefits varies.
MiSight generally fits school-age and older children, often starting around ages 8 to 12, who are motivated enough to insert, remove, and care for a lens with a parent's help early on. Because each lens is fresh and discarded nightly, there is no solution or storage case to manage. A child with significant astigmatism may not be an ideal candidate, one of the details Dr. Julakanti checks at the fitting. To do their job, the lenses need to be worn most waking hours, generally at least ten hours a day, six or more days a week, until the eyes stop growing and the prescription settles.
Not every Glen Mills child is ready to handle a contact lens, and for those families a single bedtime eye drop can be a welcome alternative. Low-dose atropine has become one of the most talked-about ways to slow childhood myopia, and for the right child it is simple and well tolerated. Because it asks so little of the child, it is a frequent starting point for younger patients.
Atropine is a long-established eye medication. At the very dilute concentrations used for myopia control, usually between 0.01% and 0.05%, it is prescribed off-label to slow the eye's elongation over time. This is a different job, and a far weaker strength, than the dilating drops used during a comprehensive eye exam, which is why the side effects people associate with atropine are usually minimal at these low doses.
The appeal is the simplicity. One drop goes into each eye at bedtime, folded into the evening routine, and the child wears their usual glasses by day. There is nothing to insert, clean, or store. Because the dose is so low, many children feel no difference at all, though a few notice slight light sensitivity or a small change in close focus, which we watch for and can ease by adjusting the concentration.
Part of what makes atropine work well as a managed treatment is that the strength can be dialed in. We often begin at a lower concentration and adjust based on how the prescription responds over the following months. It is not a set-and-forget drop; it is a plan our optometric team revisits at each follow-up, watching both the rate of progression and how comfortably your child tolerates the drop.
Both MiSight 1 day lenses and low-dose atropine drops are proven, evidence-based ways to slow how fast a child's nearsightedness advances. Neither one cures myopia, and neither behaves identically in every child, so the right pick depends on your child rather than a fixed protocol. We weigh age and maturity, the current prescription and how quickly it is changing, comfort with a contact lens, the degree of astigmatism, daily activities, and what your family prefers.
As a rule of thumb, MiSight suits an older, contact-lens-ready child who is comfortable wearing a lens during the day, while low-dose atropine suits a younger child, a child not yet ready for lenses, or a family that prefers a simple nightly drop with glasses worn by day. Some children begin with one method and switch as they grow, and in selected cases the two are combined. Whichever route we take, myopia control is a managed plan: we measure the prescription, and where useful the length of the eye, at regular visits and adjust over time. Results vary from child to child, and our goal is the best outcome for yours.
A question we hear often from Glen Mills parents is simply, "When should we start?" Timing matters with myopia, because the childhood years are when most progression happens, and catching it early gives a control plan the most room to work. Many families make the short drive to our West Chester office for a first evaluation precisely because they noticed an early sign and wanted to act rather than wait.
Children do not always tell you they cannot see well, because they assume blurry distance vision is normal. Watch for squinting at the television or whiteboard, sitting unusually close to screens, holding books very near the face, frequent eye rubbing, or a dip in classroom performance that does not match a child's ability. A first prescription that lands earlier than a parent expected, or one that jumps noticeably between annual exams, is also a signal worth taking seriously.
Myopia tends to progress fastest during the early years after it appears, and a child who becomes nearsighted at a young age has more growing years ahead in which the eye can elongate. Beginning a control plan early does not stop normal eye development, but it can slow the pace of progression during this active window. The earlier we establish a baseline and begin monitoring, the sooner we can act if the prescription starts climbing quickly.
There is no single magic age, because readiness depends on the child and the method. Low-dose atropine drops, commonly 0.01% to 0.05% and used off-label, can be appropriate for younger children who are not ready to handle contacts. MiSight 1 day contact lenses are FDA-approved to slow progression and are generally introduced around ages 8 to 12, when many children can manage daily lenses. We match the method to the child's age, prescription, and maturity rather than forcing a one-size approach.
Even before any treatment begins, an early visit lets us establish a clear baseline. By measuring the prescription and tracking it over time, Dr. Mudgil, a board-certified ophthalmologist with Johns Hopkins/Wilmer fellowship training, and our optometric team can tell the difference between expected stability and concerning progression. That distinction guides when to begin treatment and how aggressively. Acting early matters because higher myopia is associated with greater lifetime risk of retinal detachment, glaucoma, and myopic maculopathy.
Myopia management works best as a long-term relationship, and at Mudgil Eye Associates your child has an unusually complete team. Dr. Reetu R. Julakanti, our residency-trained pediatric optometrist, leads the day-to-day myopia control program for Glen Mills families, fitting MiSight lenses, prescribing and adjusting low-dose atropine, and tracking each child's progress across the years of treatment. Optometrists are the backbone of children's vision care, and Dr. Julakanti's focused pediatric training is exactly what a growing, changing prescription calls for.
Working alongside her is Dr. A. Vijay Mudgil, a board-certified, fellowship-trained pediatric ophthalmologist who completed his pediatric ophthalmology and strabismus fellowship at the Wilmer Eye Institute at Johns Hopkins and has cared for Delaware County and Chester County families for more than 20 years. He has been named a Main Line Today Top Doctor since 2009. Having both an optometrist and a fellowship-trained pediatric ophthalmologist in one practice means that if your child ever needs more than myopia control, from a stubborn prescription to eye misalignment or a medical concern, that expertise is already part of the care team, with no new referral and no starting over.
Learn more about our pediatric eye care for children of all ages, or explore our full myopia management program for Chester County families.
Yes. Dr. Reetu Julakanti, our pediatric optometrist, fits FDA-approved MiSight 1 day contact lenses for children in the Glen Mills area. MiSight is a soft daily-disposable lens worn during the day that corrects vision and is proven to slow the progression of myopia in children.
Both are proven, evidence-based ways to slow how fast a child's nearsightedness progresses. MiSight suits an older child ready to handle a daily contact lens; low-dose atropine, a simple nightly eye drop, suits younger children or those not ready for contacts. Dr. Julakanti helps you choose and adjusts the plan over time.
Myopia control combines proven treatments, MiSight 1 day contact lenses and low-dose atropine, with lifestyle steps like more time outdoors. Glen Mills-area families see Dr. Julakanti, who builds a plan for each child and monitors progress at regular visits. Slowing progression matters because higher myopia raises the lifetime risk of eye problems later in life.
Myopia control works best when it begins early, while the eye is still growing and there is the most future change left to prevent. Many Glen Mills children start between about ages 6 and 12, often at the first sign a prescription is climbing, though there is no single perfect age. Because the goal is to limit future change, starting sooner usually means a lower final prescription. If your child is newly nearsighted or the numbers are moving, an evaluation now beats waiting.
No. Myopia control does not cure nearsightedness or undo the prescription your child already has. Its job is to slow how quickly the myopia progresses during the growing years, so your child ends up less nearsighted than they otherwise would. Your child will still wear glasses or contacts to see clearly, and results vary from child to child.
Neither is better for every child; the right fit depends on yours. MiSight 1 day lenses suit an older, contact-lens-ready child who is comfortable wearing a lens during the day. Low-dose atropine, a simple nightly drop with glasses worn by day, suits younger children or those not ready for contacts. Both are evidence-based and proven to slow progression, and Dr. Julakanti helps you choose based on age, prescription, comfort with lenses, and lifestyle.
Yes. Myopia control tends to fit active Glen Mills kids well. MiSight 1 day lenses are worn during the day and correct distance vision while they are worn, which many children prefer for sports, and each lens is thrown away at night. Low-dose atropine is a bedtime drop, so it never interferes with daytime activity; the child simply wears their regular glasses or sports eyewear. We are glad to talk through protective eyewear for your child's sport. Results vary from child to child.
For most children it meaningfully slows the rate of progression, though it does not stop it entirely or reverse existing nearsightedness. In its multi-year clinical study, MiSight was associated with roughly a 59 percent reduction in the rate of progression over three years, and low-dose atropine has slowed progression across multiple studies. These are clinical-study findings; how much any individual child benefits varies, which is why we monitor and adjust at regular visits.
Treatment usually continues through the growing years, until the eyes stop changing and the prescription stabilizes, often in the mid-to-late teens or early adulthood. Stopping is something we plan together rather than do abruptly, and we guide the timing based on how your child's eyes are behaving. Regular follow-up visits are part of the plan throughout.
Low-dose atropine is used off-label for myopia control; the low concentrations involved, commonly 0.01% to 0.05%, have a long track record in eye care and are generally very well tolerated. MiSight, by contrast, is FDA-approved specifically to slow myopia progression in children. Most children on atropine have no side effects, while a few notice mild light sensitivity or a slight effect on near focus, which we can manage by adjusting the concentration.
You do not need a referral to schedule a myopia evaluation. Coverage varies by plan, and some services or materials may not be covered by medical insurance, so our team reviews the details with you before treatment begins. Call our West Chester office at (610) 429-3004 and we will walk you through the options.
Most Glen Mills families are seen within one to two weeks for an initial myopia evaluation. Call 610-429-3004 or schedule online, and we will help you get ahead of your child's nearsightedness.